228 related articles for article (PubMed ID: 37630763)
1. Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and
Crocetto F; Balsamo R; Amicuzi U; De Luca L; Falcone A; Mirto BF; Giampaglia G; Ferretti G; Capone F; Machiella F; Varriale D; Sicignano E; Pagano G; Lombardi A; Lucarelli G; Lasorsa F; Busetto GM; Del Giudice F; Ferro M; Imbimbo C; Barone B
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630763
[TBL] [Abstract][Full Text] [Related]
2. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
Tasdemir S; Tasdemir C; Vardi N; Yakupogullari Y; Duman Y; Parlakpinar H; Sagir M; Acet A
Int J Urol; 2012 Dec; 19(12):1108-12. PubMed ID: 22852837
[TBL] [Abstract][Full Text] [Related]
3. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial.
Damiano R; Quarto G; Bava I; Ucciero G; De Domenico R; Palumbo MI; Autorino R
Eur Urol; 2011 Apr; 59(4):645-51. PubMed ID: 21272992
[TBL] [Abstract][Full Text] [Related]
4. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis.
Goddard JC; Janssen DAW
Int Urogynecol J; 2018 Jul; 29(7):933-942. PubMed ID: 29181550
[TBL] [Abstract][Full Text] [Related]
5. Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury.
King GK; Goodes LM; Hartshorn C; Thavaseelan J; Jonescu S; Watts A; Rawlins M; Woodland P; Synnott EL; Barrett T; Hayne D; Boan P; Dunlop SA
J Spinal Cord Med; 2023 Sep; 46(5):830-836. PubMed ID: 35792831
[TBL] [Abstract][Full Text] [Related]
6. Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study.
Ciani O; Arendsen E; Romancik M; Lunik R; Costantini E; Di Biase M; Morgia G; Fragalà E; Roman T; Bernat M; Guazzoni G; Tarricone R; Lazzeri M
BMJ Open; 2016 Mar; 6(3):e009669. PubMed ID: 27033958
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment to intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
Damiano R; Cicione A
Int J Urol; 2012 Dec; 19(12):1112-3. PubMed ID: 23181521
[No Abstract] [Full Text] [Related]
8. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
[TBL] [Abstract][Full Text] [Related]
9. Adhesion blockers: a paradigm shift in the treatment of urinary tract infections.
Lazzeri M; Guazzoni G; Montorsi F
Eur Urol; 2012 Aug; 62(2):355-6. PubMed ID: 22561077
[No Abstract] [Full Text] [Related]
10. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).
Costantini E; Lazzeri M; Pistolesi D; Del Zingaro M; Frumenzio E; Boni A; Pietropaolo A; Fragalà E; Porena M
Urol Int; 2013; 91(1):81-8. PubMed ID: 23485915
[TBL] [Abstract][Full Text] [Related]
11. Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment.
Schiavi MC; Porpora MG; Vena F; Prata G; Sciuga V; D'Oria O; Di Tucci C; Savone D; Aleksa N; Giannini A; Nusiner MP; Zullo MA; Muzii L; Benedetti Panici P
Female Pelvic Med Reconstr Surg; 2019; 25(4):309-312. PubMed ID: 29389678
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of intravesical chondroitin sulphate solution in recurrent urinary tract infections.
Rahnama'i MS; Javan Balegh Marand A; Röschmann-Doose K; Steffens L; Arendsen HJ
BMC Urol; 2022 Nov; 22(1):188. PubMed ID: 36424583
[TBL] [Abstract][Full Text] [Related]
13. Effect of highly concentrated hyaluronic acid/chondroitin sulphate instillation on ureteric stent-induced discomfort after ureteroscopic lithotripsy: a multicentre randomised controlled pilot study.
Jo JK; Kim JH; Kim KS; Chung JH; Kim YT; Choi HY; Song ES; Lee B; Lee SW
BJU Int; 2018 Nov; 122(5):858-865. PubMed ID: 29772114
[TBL] [Abstract][Full Text] [Related]
14. [Recurrent urinary tract infections: prevention of recurrence with intravesical instillations of chondroitin sulfate and hyaluronic acid.].
Tornero Ruiz JI; Martínez Gómez G; Escudero Bregante JF; Gómez Gómez GA
Arch Esp Urol; 2017 Mar; 70(2):288-293. PubMed ID: 28300032
[TBL] [Abstract][Full Text] [Related]
15. Intravesical instillation of hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections.
Martínez-Pizarro S
Actas Urol Esp (Engl Ed); 2020 Oct; 44(8):568-569. PubMed ID: 32600876
[No Abstract] [Full Text] [Related]
16. Role of D-mannose in urinary tract infections - a narrative review.
Ala-Jaakkola R; Laitila A; Ouwehand AC; Lehtoranta L
Nutr J; 2022 Mar; 21(1):18. PubMed ID: 35313893
[TBL] [Abstract][Full Text] [Related]
17. Role of D-Mannose in the Prevention of Recurrent Urinary Tract Infections: Evidence from a Systematic Review of the Literature.
Kyriakides R; Jones P; Somani BK
Eur Urol Focus; 2021 Sep; 7(5):1166-1169. PubMed ID: 32972899
[TBL] [Abstract][Full Text] [Related]
18. Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control analysis.
Gugliotta G; Calagna G; Adile G; Polito S; Saitta S; Speciale P; Palomba S; Perino A; Granese R; Adile B
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):537-40. PubMed ID: 26522106
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?
Iavazzo C; Athanasiou S; Pitsouni E; Falagas ME
Eur Urol; 2007 Jun; 51(6):1534-40; discussion 1540-1. PubMed ID: 17383810
[TBL] [Abstract][Full Text] [Related]
20. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation.
Palleschi G; Carbone A; Zanello PP; Mele R; Leto A; Fuschi A; Al Salhi Y; Velotti G; Al Rawashdah S; Coppola G; Maurizi A; Maruccia S; Pastore AL
Arch Ital Urol Androl; 2017 Mar; 89(1):45-50. PubMed ID: 28403598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
